#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	275	15124	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2322	648.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	707	707	G	832	G	753	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3528	774.1	0	.	n	.	0	A20C	SNP	20	20	A	360	360	C	611	C,A	374,199	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3528	774.1	0	.	n	.	0	T695C	SNP	695	695	T	1035	1035	C	831	C,T	774,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3528	774.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1978	1978	G	925	G	865	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3528	774.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2311	2311	C	843	C	772	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3528	774.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2385	2385	A	847	A	786	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27390	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3528	774.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2937	2937	C	842	C	783	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1972	folP	855	855	100.0	folP.l15.c4.ctg.1	1442	135.6	1	SNP	p	R229S	1	.	.	685	687	AGC	948	950	AGC	198;198;197	A;G;C	190;191;189	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4880	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3295	147.0	1	SNP	p	S91F	1	.	.	271	273	TTC	581	583	TTC	181;180;181	T;T;C	168;169;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4880	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3295	147.0	1	SNP	p	G95N	0	.	.	283	285	GGC	593	595	GGC	187;185;186	G;G;C	176;171;174	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4880	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3295	147.0	1	SNP	p	D95G	1	.	.	283	285	GGC	593	595	GGC	187;185;186	G;G;C	176;171;174	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1530	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1394	108.7	0	.	p	.	0	F184L	NONSYN	550	552	TTC	1066	1068	TTG	158;158;156	T;T;G,C	148;148;142,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1530	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1394	108.7	1	SNP	p	G45D	0	.	.	133	135	GGC	649	651	GGC	191;192;196	G;G,A;C,T	179;178,1;182,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	734	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1030	70.8	0	.	n	.	0	A197.	DEL	197	197	A	624	624	A	178	A	164	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	174.3	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	205;205;208	G;A;C	191;188;194	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	174.3	1	SNP	p	R87I	0	.	.	259	261	CGT	553	555	CGT	206;205;210	C;G;T	190;189;190	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	174.3	1	SNP	p	S87R	1	.	.	259	261	CGT	553	555	CGT	206;205;210	C;G;T	190;189;190	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	174.3	1	SNP	p	R87W	0	.	.	259	261	CGT	553	555	CGT	206;205;210	C;G;T	190;189;190	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5162	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2949	174.3	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	209;207;210	T;C;C	189;190;192	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4368	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2783	156.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1629	1631	GGC	255;254;252	G;G;C	222;221;220	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1285	1287	GCA	214;216;215	G;C;A	192;193;194	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1288	1290	ATC	216;215;216	A;T;C	198;196;194	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1300	1302	GTG	217;213;219	G;T;G	203;198;199	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1300	1302	GTG	217;213;219	G;T;G	203;198;199	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1804	1806	ACC	195;194;193	A;C;C,T	174;173;175,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1858	1860	GCG	202;199;202	G;C;G	174;148;167	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1858	1860	GCG	202;199;202	G;C;G	174;148;167	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1981	1983	AGC	171;170;170	A;G;C	162;161;158	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1990	1992	GGC	168;167;167	G;G;C	155;155;154	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3950	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	162.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2008	2010	CCG	149;150;155	C,G;C;G	105,4;106;111	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5310	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3164	167.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1670	1672	CCG	210;211;206	C;C;G	178;190;174	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2262	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1800	124.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	563	563	C	157	C	145	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	T26A	NONSYN	76	78	ACC	399	401	GCC	254;251;249	G;C;C	228;220;223	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	435	437	GAA	243;242;240	G;A;A	221;219;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	K41D	NONSYN	121	123	AAA	444	446	GAC	236;236;234	G;A;C	218;216;219	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	K120N	NONSYN	358	360	AAG	681	683	AAC	249;251;248	A;A;C,G	228;230;227,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	723	725	GAT	239;235;238	G;A;T	224;222;223	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	846	848	TCA	242;243;245	T;C;A	219;223;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	A218T	NONSYN	652	654	GCC	975	977	ACC	205;205;204	A,G;C;C	190,1;194;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	987	989	TCT	203;206;213	T;C,T;T	193;193,1;198	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1305	1307	GCA	194;195;197	G;C;A	176;177;180	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	1	SNP	p	A121D	1	.	.	361	363	GAC	684	686	GAC	249;246;247	G;A;C	228;226;229	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2790	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1512	183.4	1	SNP	p	D121N	0	.	.	361	363	GAC	684	686	GAC	249;246;247	G;A;C	228;226;229	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10708	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5036	212.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1146	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	936	121.2	1	SNP	p	V57M	1	.	.	169	171	ATG	480	482	ATG	245;244;246	A;T,C;G	224;224,1;225	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
